Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


51 More Hospitals Join Federal ICD Settlement

This article was originally published in The Gray Sheet

Executive Summary

The Department of Justice says the additional 51 hospitals that settled with the government on charges of billing for ICD implants outside of Medicare coverage guidelines represent the "final stage" of a long-running investigation. DoJ previously identified another 457 hospitals that have settled. Hospitals payments tied to the investigation total $273 million.

You may also be interested in...

Medicare Agency Solicits Input On ICD Coverage For First Time Since 2005

The US Medicare agency opened a national coverage analysis to reconsider coverage indications for implantable cardioverter defibrillators and received input from 35 individuals, organizations, and companies during the initial public comment period. The agency did not specify any particular issues or deficiencies that it wants to address by updating its coverage policy, but CMS has not reconsidered the national coverage policy on ICDs since a major coverage expansion was implemented in 2005.

Medtech And US DoJ: A Snapshot Of 2016 Pay-Outs And Pleas

The US Department of Justice has announced resolution of 14 device-related investigations in 2016, including settlements, guilty pleas and a few executive convictions. The largest settlement this year, with Olympus Corp., accounted for almost three-quarters of the $825.5m total value of medtech fines in 2016.

ICD Settlements Raise Questions On Role Of NCDs As False-Claims Standard

Attorneys who work on False Claims allegations are pleased by the $250 million settlement on ICDs installed outside Medicare coverage policy, but electrophysiologists say the policy is out of date. But it's not clear that national coverage determinations will be a frequent source of false-claims suits in other device sectors.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts